Together with an additional defining element of PDAC, i.e., increased insulin levels, this activation allows augmented uptake of glucose by the tumor cells through GLUT4 membrane translocation, thus promoting growth and chemoresistance of PDAC. The gene discussed is INS; the disease is neoplasm.